Organogenesis Holdings Inc. to Participate in the Credit Suisse 30th Annual Healthcare Conference
Organogenesis Holdings (Nasdaq: ORGO) will participate in the Credit Suisse 30th Annual Healthcare Conference from November 8-11, 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Organogenesis Holdings (Nasdaq: ORGO) will participate in the Credit Suisse 30th Annual Healthcare Conference from November 8-11, 2021. A fireside chat featuring company management is scheduled for November 11 at 9:40 a.m. ET. The event will be held virtually, and a live audio webcast will be accessible via the ‘Upcoming Events’ section on Organogenesis’s Investor Relations page. An archived version of the webcast will be available for 30 days post-conference.
Organogenesis specializes in regenerative medicine, offering bioactive products for advanced wound care and surgical markets.
Details
News Market Reaction – ORGO
The recorded move for ORGO in the trading session of this news was +4.44%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CANTON, Mass., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today announced that company management will participate in the Credit Suisse 30th Annual Healthcare Conference, which is being held virtually from November 8th-11th. Management will participate in a fireside chat on Thursday, November 11th at 9:40 a.m. Eastern Time.
A live audio webcast of the conference presentation will be accessible by visiting the “Upcoming Events” section on the “Investor Relations” page of Organogenesis’s website www.organogenesis.com. An archive of the webcast will be available for replay following the conference for approximately 30 days.
About Organogenesis Holdings Inc.
Organogenesis Holdings Inc. is a leading regenerative medicine company offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. Organogenesis’s comprehensive portfolio is designed to treat a variety of patients with repair and regenerative needs.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.